Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News SK Biopharmaceuticals bags XCOPRI FDA approval for partial-onset seizures XCOPRI FDA approval : SK Biopharmaceuticals said that its US subsidiary SK Life Science has been granted approval from… bypharmanewsdailyNovember 23, 2019